NuCana plc (NCNA)

Nasdaq Pharmaceutical Pharmaceutical Preparations SIC: 2834
D
Pipeline Grade

Drug Pipeline (0 Assets)

No drugs indexed yet. Pipeline data is populated from ClinicalTrials.gov and openFDA.

Upcoming Catalysts

DateEventDrug
2026-08-01 Phase2 Readout

Active Clinical Trials (1)

NCT #TitlePhaseStatusEnrollment
NCT03829254 A Safety, Pharmacokinetic and Clinical Activity Study of NUC-7738 in Patients With Advanced Solid Tumours and Lymphoma PHASE2 Recruiting 135

Source: ClinicalTrials.gov. Trial status last updated by sponsor — may not reflect current state.

More Analysis